Analysis Metabolite Name Measured Value Units Cell Type Stimulation
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+CL)-108549Peak areaBS4 IL-17A
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+CL)-Peak areaBS4 IFN-G
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+CL)-Peak areaBS4 TNF-alpha
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+CL)-Peak areaBS4 TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+CL)-Peak areaBS4 Untreated
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+CL)-Peak areaHAHA IFN-G
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+CL)-Peak areaHAHA IL-17A
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+CL)-Peak areaHAHA TNF-alpha
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+CL)-Peak areaHAHA TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+CL)-Peak areaHAHA Untreated
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+CL)-Peak areaPAK IFN-G
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+CL)-Peak areaPAK IL-17A
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+CL)-Peak areaPAK TNF-alpha
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+CL)-Peak areaPAK TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+CL)-Peak areaPAK Untreated
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+HCOO)-1989Peak areaPAK TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+HCOO)-3387Peak areaHAHA TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+HCOO)-8687Peak areaPAK TNF-alpha
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+HCOO)-11259Peak areaHAHA IL-17A
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+HCOO)-34227Peak areaBS4 IL-17A
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+HCOO)-38838Peak areaPAK IFN-G
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+HCOO)-42100Peak areaBS4 TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+HCOO)-49768Peak areaPAK IL-17A
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+HCOO)-54629Peak areaBS4 IFN-G
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+HCOO)-54757Peak areaBS4 Untreated
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+HCOO)-80236Peak areaBS4 TNF-alpha
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+HCOO)-Peak areaHAHA IFN-G
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+HCOO)-Peak areaHAHA TNF-alpha
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+HCOO)-Peak areaHAHA Untreated
Reversed phase NEGATIVE ION MODEADENOSINE (CAS# 58-61-7); (M+HCOO)-Peak areaPAK Untreated
Reversed phase POSITIVE ION MODEADENOSINE (CAS# 58-61-7); (M+H)+58400Peak areaPAK TNF-alpha
Reversed phase POSITIVE ION MODEADENOSINE (CAS# 58-61-7); (M+H)+76948Peak areaPAK TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODEADENOSINE (CAS# 58-61-7); (M+H)+100059Peak areaHAHA Untreated
Reversed phase POSITIVE ION MODEADENOSINE (CAS# 58-61-7); (M+H)+114324Peak areaHAHA TNF-alpha
Reversed phase POSITIVE ION MODEADENOSINE (CAS# 58-61-7); (M+H)+223472Peak areaHAHA IL-17A
Reversed phase POSITIVE ION MODEADENOSINE (CAS# 58-61-7); (M+H)+226817Peak areaHAHA TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODEADENOSINE (CAS# 58-61-7); (M+H)+528564Peak areaHAHA IFN-G
Reversed phase POSITIVE ION MODEADENOSINE (CAS# 58-61-7); (M+H)+858381Peak areaPAK Untreated
Reversed phase POSITIVE ION MODEADENOSINE (CAS# 58-61-7); (M+H)+901686Peak areaBS4 IL-17A
Reversed phase POSITIVE ION MODEADENOSINE (CAS# 58-61-7); (M+H)+1387975Peak areaPAK IFN-G
Reversed phase POSITIVE ION MODEADENOSINE (CAS# 58-61-7); (M+H)+1430397Peak areaPAK IL-17A
Reversed phase POSITIVE ION MODEADENOSINE (CAS# 58-61-7); (M+H)+1551741Peak areaBS4 TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODEADENOSINE (CAS# 58-61-7); (M+H)+1717794Peak areaBS4 IFN-G
Reversed phase POSITIVE ION MODEADENOSINE (CAS# 58-61-7); (M+H)+1969612Peak areaBS4 Untreated
Reversed phase POSITIVE ION MODEADENOSINE (CAS# 58-61-7); (M+H)+2382960Peak areaBS4 TNF-alpha

Return to search page
  logo